Mental HealthIFPMA Announces Johnson & Johnson As New Member Company
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Johnson & Johnson has become its newest member company.
IFPMA Acting Director General Michael D. Boyd said: "Johnson & Johnson is an important company in our industry and one which is particularly active in working to help improve health in developing countries. The IFPMA is very pleased that Johnson & Johnson has joined; this is good for the IFPMA, and we expect it will benefit Johnson & Johnson, as well."
Johnson & Johnson is the world"s most comprehensive healthcare company, with more than 250 companies in 57 countries employing 119,000 people worldwide engaged in the research and development, manufacture and sales of a broad range of health care products, including pharmaceuticals, medical devices and diagnostics. Its worldwide headquarters is in New Brunswick, New Jersey, USA.
The company is committed to bringing innovative ideas, products and services to market that advance the health and well-being of people throughout the world.
For general information on Johnson & Johnson, please go to http://www.jnj.com. For information on the company"s activities to help improve health in underserved communities, please go to http://www.jnj.com/connect/caring/medicine-access/.
IFPMA